Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

409
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
409
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

978
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
978
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

138
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
138
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

155
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
155
Lipid Absorption01:24

Lipid Absorption

1.9K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).

JACC. Advances·2026
Same author

The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fontan.

Pediatric cardiology·2026
Same author

The Proteomic Profile of Adults With a Fontan Circulation.

JACC. Advances·2026
Same author

Bile Acids, Mitochondria, and Myocardial Stiffness: A Shared Mechanism in Fontan Circulation and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Circulation. Heart failure·2026
Same author

Rare <i>KDR</i> Variants Define a Distinct Genetic Contribution to Congenital Heart Disease.

Circulation. Genomic and precision medicine·2026
Same author

The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.

Circulation·2026

Related Experiment Video

Updated: Nov 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Fontan-Associated Dyslipidemia.

Adam M Lubert1, Tarek Alsaied1, Joseph J Palermo2

  • 1Department of Pediatrics Cincinnati Children's Hospital Heart InstituteUniversity of Cincinnati College of Medicine Cincinnati OH.

Journal of the American Heart Association
|March 31, 2021
PubMed
Summary
This summary is machine-generated.

Adults with Fontan circulation have lower cholesterol levels, particularly high-density lipoprotein cholesterol (HDL-C). Lower HDL-C is linked to increased risk of hospitalization or death, possibly due to inflammation.

Keywords:
Fontanadult congenital heart diseasehigh‐density lipoprotein cholesterollipidssingle ventricle

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

7.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.8K

Related Experiment Videos

Last Updated: Nov 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

7.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.8K

Area of Science:

  • Cardiology
  • Hepatology
  • Biochemistry

Background:

  • Hypocholesterolemia is a known indicator of liver disease.
  • Patients with Fontan circulation may experience hypocholesterolemia due to Fontan-associated liver disease or inflammation.

Purpose of the Study:

  • To investigate circulating lipid profiles in adults with Fontan circulation.
  • To assess the associations between lipid levels, clinical characteristics, and adverse events in this population.

Main Methods:

  • 164 outpatients with Fontan circulation (≥18 years) were compared with 81 healthy controls.
  • Circulating lipids, including total cholesterol, LDL-C, and HDL-C, were measured.
  • Adverse outcomes (nonelective cardiovascular hospitalization or death) were tracked.

Main Results:

  • Fontan circulation patients had significantly lower total cholesterol, LDL-C, and HDL-C compared to controls.
  • Lower HDL-C was inversely correlated with body mass index, hs-CRP, and ALT.
  • Lower HDL-C was independently associated with increased hazard for adverse outcomes, an association potentially mediated by inflammation.

Conclusions:

  • Fontan circulation is associated with reduced cholesterol levels, especially HDL-C.
  • Low HDL-C is a predictor of adverse outcomes in Fontan patients.
  • Inflammation may play a significant role in the observed lipid metabolism alterations and outcomes.